Mesoporous Silica Nanoparticles for the Treatment of Complex Bone Diseases: Bone Cancer, Bone Infection and Osteoporosis

Abstract

Bone diseases, such as bone cancer, bone infection and osteoporosis, constitute a major issue for modern societies as a consequence of their progressive ageing. Even though these pathologies can be currently treated in the clinic, some of those treatments present drawbacks that may lead to severe complications. For instance, chemotherapy lacks great tumor tissue selectivity, affecting healthy and diseased tissues. In addition, the inappropriate use of antimicrobials is leading to the appearance of drug-resistant bacteria and persistent biofilms, rendering current antibiotics useless. Furthermore, current antiosteoporotic treatments present many side effects as a consequence of their poor bioavailability and the need to use higher doses. In view of the existing evidence, the encapsulation and selective delivery to the diseased tissues of the different therapeutic compounds seem highly convenient. In this sense, silica-based mesoporous nanoparticles offer great loading capacity within their pores, the possibility of modifying the surface to target the particles to the malignant areas and great biocompatibility. This manuscript is intended to be a comprehensive review of the available literature on complex bone diseases treated with silica-based mesoporous nanoparticles—the further development of which and eventual translation into the clinic could bring significant benefits for our future society.

Mesoporous Silica Nanoparticles in Bioimaging

“…; see Table 1 ). In recent years, mesoporous silica nanomaterials (MSNs) have been widely used for a wide range of applications such as those spanning drug delivery [ 3 , 4 , 5 , 6 ], diagnostics [ 7 ] and catalysis [ 8 ].…”

Silica Mesoporous Structures: Effective Nanocarriers in Drug Delivery and Nanocatalysts

“…In recent decades, significant advancements in pharmaceutical industry and medicinal chemistry have led to deep understanding of physico-chemical properties of medical compounds and provided the opportunity for recognition of cellular absorption strategies for effective treatments [160][161][162][163][164]. Initially, in some cases, such as chemotherapy for cancer, therapeutic methods relied on the use of toxic drugs with undesirable complications and limited beneficial effects [165].…”

Studies on the Exposure of Gadolinium Containing Nanoparticles with Monochromatic X-rays Drive Advances in Radiation Therapy

“…In the next couple of sections, we describe Gd–MSN in more detail. These nanoparticles are based on mesoporous silica nanoparticles (MSN) that have a number of advantageous features among various nanoparticles including the ease of synthesis and chemical modifications [ 40 , 41 , 42 , 43 , 44 ]. They are synthesized by the sol–gel method that involves condensation of TEOS (tetraethyl orthosilicate) in the presence of templating surfactant solution.…”